Terminated PHASE2 INTERVENTIONAL NCT00296556

Therapeutic Study of ONO-4819CD for Ulcerative Colitis

A Randomized, Placebo-Controlled Trial of ONO-4819CD for Treatment of Mild to Moderate Ulcerative Colitis.

Sponsor: Kyoto University, Graduate School of Medicine

Updated 5 times since 2017 Last updated: Apr 27, 2009 Started: Feb 28, 2006 Primary completion: Dec 31, 2007 Completion: Mar 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

terminated

Other Ulcerative Colitis trials with similar outcome

Browse all Ulcerative Colitis trials

This PHASE2 trial investigates Ulcerative Colitis and is currently terminated or withdrawn. Kyoto University, Graduate School of Medicine leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Feb 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kyoto University, Graduate School of Medicine
National Institute of Biomedical Innovation

Data source: Kyoto University, Graduate School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kyoto, Japan